Cargando…

Immuno-imaging and -therapy in ovarian cancer and sarcoma with de novo single-chain fv-fc fusion protein targeting TEM1/CD248

Detalles Bibliográficos
Autores principales:	Li, Chunsheng, Wang, Junying, Matthaiou, Efthymia Iliana, Guo, Yi, Hu, Jia, Chacko, Ann Marie, Muzykantov, Vladimir R, Coukos, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292446/ http://dx.doi.org/10.1186/2051-1426-2-S3-P219

Ejemplares similares

Immunotargeting of tumor vasculature: preclinical development of novel antibody-based imaging and therapy against TEM1/CD248
por: Li, Chunsheng, et al.
Publicado: (2013)

Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer
por: Li, Chunsheng, et al.
Publicado: (2014)

TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer
por: Matthaiou, Efthymia-Iliana, et al.
Publicado: (2022)

(177)Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma
por: Delage, J. A., et al.
Publicado: (2020)

Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
por: Matthaiou, Efthymia-Iliana, et al.
Publicado: (2014)

Preclinical Evaluation and Dosimetry of [(111)In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1)
por: Cicone, Francesco, et al.
Publicado: (2020)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [(177)Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model
por: Delage, Judith Anna, et al.
Publicado: (2021)

Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor
por: Greineder, Colin F., et al.
Publicado: (2013)

(89)Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo
por: Alizadeh, Elahe, et al.
Publicado: (2021)

Macrophage Lysosomal Alkalinization Drives Invasive Aspergillosis in a Mouse Cystic Fibrosis Model of Airway Transplantation
por: Matthaiou, Efthymia Iliana, et al.
Publicado: (2022)

Immuno-PET Imaging of Tumor Endothelial Marker 8 (TEM8)
por: Kuo, Frank, et al.
Publicado: (2014)

TEM, SEM, and STEM-based immuno-CLEM workflows offer complementary advantages
por: Oorschot, Viola, et al.
Publicado: (2021)

Generation of 1E8 Single Chain Fv-Fc Construct Against Human CD59
por: Hong, Jeong-Won, et al.
Publicado: (2012)

Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins
por: Kim, Hye-Yeon, et al.
Publicado: (2021)

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E
por: Miethe, Sebastian, et al.
Publicado: (2015)

Characterization of the single-chain Fv-Fc antibody MBP10 produced in Arabidopsis alg3 mutant seeds
por: Henquet, Maurice, et al.
Publicado: (2010)

Cd248a and Cd248b in zebrafish participate in innate immune responses
por: Li, Xianpeng, et al.
Publicado: (2022)

Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment
por: Girgis, Mark D, et al.
Publicado: (2011)

Retargeting T Cells for HER2-Positive Tumor Killing by a Bispecific Fv-Fc Antibody
por: Wang, Lei, et al.
Publicado: (2013)

Cre-mediated cellular modification for establishing producer CHO cells of recombinant scFv-Fc
por: Kawabe, Yoshinori, et al.
Publicado: (2015)

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2015)

Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library
por: Miethe, Sebastian, et al.
Publicado: (2014)

Health Tract, No. 248: Weights and Measures
Publicado: (1866)

Kaposi’s sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania
por: Chalya, Phillipo L., et al.
Publicado: (2015)

Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity
por: Schultheis, Katherine, et al.
Publicado: (2020)

A Multiplex PCR Melting-Curve-Analysis-Based Detection Method for the Discrimination of Five Aspergillus Species
por: Tokamani, Maria, et al.
Publicado: (2023)

Etymologia: TEM
por: Ruiz, Joaquim
Publicado: (2018)

P248 Fungal meningitis in an immunocompetent individual
por: Ningthoujam, Priyolakshmi, et al.
Publicado: (2022)

Clinical Applications of Phage-Derived sFvs and sFv Fusion Proteins
por: Chester, K. A., et al.
Publicado: (2000)

Recapitulation of acquired immuno deficiency syndrome associated Kaposi's sarcoma
por: Govindan, Balaji
Publicado: (2016)

Vector design for enhancing expression level and assembly of knob-into-hole based FabscFv-Fc bispecific antibodies in CHO cells
por: Ong, Han Kee, et al.
Publicado: (2022)

Correction to Lancet Oncol 2016; 17: 248, 252
Publicado: (2016)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
por: Suzuki, Takuo, et al.
Publicado: (2021)

Incidence and clinical characteristics of unexpected uterine sarcoma after hysterectomy and myomectomy for uterine fibroids: a retrospective study of 10,248 cases
por: Zhao, Wan-Cheng, et al.
Publicado: (2015)

Site-specific Conjugation of 6 DOTA Chelators to a CA19-9-targeting scFv-Fc Antibody for Imaging and Therapy
por: Chen, Li-An, et al.
Publicado: (2023)

The Instability of Dimeric Fc-Fusions Expressed in Plants Can Be Solved by Monomeric Fc Technology
por: Gattinger, Pia, et al.
Publicado: (2021)

Anti-PSMA (124)I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle
por: Frigerio, B., et al.
Publicado: (2019)

Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
por: Liu, Liming
Publicado: (2017)

Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
por: Cui, Xiaoteng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jk2vmvodnr4vukj279g40lk17h